nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—PPARG—melanoma	0.469	0.703	CbGaD
Icosapent—PTGS2—melanoma	0.198	0.297	CbGaD
Icosapent—PPARG—dermis—melanoma	0.00886	0.0916	CbGeAlD
Icosapent—PPARG—leg—melanoma	0.00585	0.0604	CbGeAlD
Icosapent—PPARG—hindlimb—melanoma	0.00522	0.054	CbGeAlD
Icosapent—PPARG—appendage—melanoma	0.00448	0.0463	CbGeAlD
Icosapent—FABP7—eye—melanoma	0.00358	0.037	CbGeAlD
Icosapent—FABP7—retina—melanoma	0.00355	0.0367	CbGeAlD
Icosapent—ACSL3—head—melanoma	0.00333	0.0345	CbGeAlD
Icosapent—FADS1—eye—melanoma	0.00325	0.0336	CbGeAlD
Icosapent—FADS1—retina—melanoma	0.00322	0.0333	CbGeAlD
Icosapent—PTGS2—leg—melanoma	0.00299	0.0309	CbGeAlD
Icosapent—ACSL4—eye—melanoma	0.00295	0.0305	CbGeAlD
Icosapent—ACSL4—retina—melanoma	0.00292	0.0302	CbGeAlD
Icosapent—SLC8A1—head—melanoma	0.00276	0.0286	CbGeAlD
Icosapent—PPARG—endothelium—melanoma	0.0027	0.0279	CbGeAlD
Icosapent—PTGS2—hindlimb—melanoma	0.00267	0.0276	CbGeAlD
Icosapent—FADS1—mammalian vulva—melanoma	0.00258	0.0266	CbGeAlD
Icosapent—PPARG—blood vessel—melanoma	0.00249	0.0258	CbGeAlD
Icosapent—ACSL4—mammalian vulva—melanoma	0.00234	0.0242	CbGeAlD
Icosapent—PTGS2—appendage—melanoma	0.00229	0.0237	CbGeAlD
Icosapent—PPARD—mammalian vulva—melanoma	0.00225	0.0232	CbGeAlD
Icosapent—FABP7—head—melanoma	0.00203	0.021	CbGeAlD
Icosapent—PTGS2—skin epidermis—melanoma	0.0019	0.0197	CbGeAlD
Icosapent—TRPV1—head—melanoma	0.00184	0.0191	CbGeAlD
Icosapent—PPARG—neck—melanoma	0.00178	0.0184	CbGeAlD
Icosapent—ACSL4—head—melanoma	0.00167	0.0173	CbGeAlD
Icosapent—PPARD—head—melanoma	0.00161	0.0166	CbGeAlD
Icosapent—PTGS1—endothelium—melanoma	0.00145	0.0149	CbGeAlD
Icosapent—PTGS2—endothelium—melanoma	0.00138	0.0143	CbGeAlD
Icosapent—PTGS1—blood vessel—melanoma	0.00133	0.0138	CbGeAlD
Icosapent—FADS1—lymph node—melanoma	0.00129	0.0133	CbGeAlD
Icosapent—PTGS2—blood vessel—melanoma	0.00127	0.0132	CbGeAlD
Icosapent—ACSL4—lymph node—melanoma	0.00117	0.0121	CbGeAlD
Icosapent—PPARG—skin of body—melanoma	0.00115	0.0119	CbGeAlD
Icosapent—PPARD—lymph node—melanoma	0.00113	0.0116	CbGeAlD
Icosapent—PPARG—mammalian vulva—melanoma	0.00105	0.0109	CbGeAlD
Icosapent—PPARG—head—melanoma	0.000753	0.00779	CbGeAlD
Icosapent—PTGS1—skin of body—melanoma	0.000617	0.00638	CbGeAlD
Icosapent—PTGS2—skin of body—melanoma	0.00059	0.0061	CbGeAlD
Icosapent—PTGS1—mammalian vulva—melanoma	0.000563	0.00582	CbGeAlD
Icosapent—PPARG—lymph node—melanoma	0.000527	0.00545	CbGeAlD
Icosapent—Malnutrition—Vemurafenib—melanoma	0.000455	0.0397	CcSEcCtD
Icosapent—Dysgeusia—Vemurafenib—melanoma	0.000445	0.0389	CcSEcCtD
Icosapent—PTGS1—head—melanoma	0.000403	0.00416	CbGeAlD
Icosapent—Oropharyngeal pain—Docetaxel—melanoma	0.000389	0.0339	CcSEcCtD
Icosapent—Arthralgia—Vemurafenib—melanoma	0.000387	0.0338	CcSEcCtD
Icosapent—PTGS2—head—melanoma	0.000385	0.00398	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.000384	0.0335	CcSEcCtD
Icosapent—Anaphylactic shock—Vemurafenib—melanoma	0.000371	0.0324	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Temozolomide—melanoma	0.000347	0.0303	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Temozolomide—melanoma	0.00034	0.0297	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000338	0.0295	CcSEcCtD
Icosapent—Gastrointestinal disorder—Vemurafenib—melanoma	0.00032	0.028	CcSEcCtD
Icosapent—Constipation—Vemurafenib—melanoma	0.000317	0.0277	CcSEcCtD
Icosapent—PTGS1—lymph node—melanoma	0.000282	0.00291	CbGeAlD
Icosapent—PTGS2—lymph node—melanoma	0.000269	0.00279	CbGeAlD
Icosapent—Pruritus—Vemurafenib—melanoma	0.000263	0.0229	CcSEcCtD
Icosapent—Malnutrition—Carmustine—melanoma	0.00024	0.021	CcSEcCtD
Icosapent—Vomiting—Vemurafenib—melanoma	0.000236	0.0206	CcSEcCtD
Icosapent—Rash—Vemurafenib—melanoma	0.000234	0.0204	CcSEcCtD
Icosapent—Dermatitis—Vemurafenib—melanoma	0.000234	0.0204	CcSEcCtD
Icosapent—Malnutrition—Temozolomide—melanoma	0.000232	0.0203	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000231	0.0202	CcSEcCtD
Icosapent—Dysgeusia—Temozolomide—melanoma	0.000228	0.0199	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Docetaxel—melanoma	0.000226	0.0197	CcSEcCtD
Icosapent—Anaphylactic shock—Bleomycin—melanoma	0.000225	0.0196	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Bleomycin—melanoma	0.000205	0.0179	CcSEcCtD
Icosapent—Arthralgia—Temozolomide—melanoma	0.000198	0.0173	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000191	0.0167	CcSEcCtD
Icosapent—Anaphylactic shock—Temozolomide—melanoma	0.00019	0.0165	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Carmustine—melanoma	0.000179	0.0156	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Temozolomide—melanoma	0.000173	0.0151	CcSEcCtD
Icosapent—Gastrointestinal disorder—Carmustine—melanoma	0.000169	0.0148	CcSEcCtD
Icosapent—Constipation—Carmustine—melanoma	0.000168	0.0146	CcSEcCtD
Icosapent—Dyspepsia—Temozolomide—melanoma	0.000167	0.0146	CcSEcCtD
Icosapent—Gastrointestinal disorder—Temozolomide—melanoma	0.000164	0.0143	CcSEcCtD
Icosapent—Constipation—Temozolomide—melanoma	0.000162	0.0142	CcSEcCtD
Icosapent—Pruritus—Bleomycin—melanoma	0.000159	0.0139	CcSEcCtD
Icosapent—Malnutrition—Docetaxel—melanoma	0.000155	0.0135	CcSEcCtD
Icosapent—Dysgeusia—Docetaxel—melanoma	0.000151	0.0132	CcSEcCtD
Icosapent—Vomiting—Bleomycin—melanoma	0.000143	0.0125	CcSEcCtD
Icosapent—Rash—Bleomycin—melanoma	0.000142	0.0124	CcSEcCtD
Icosapent—Dermatitis—Bleomycin—melanoma	0.000142	0.0124	CcSEcCtD
Icosapent—Pruritus—Temozolomide—melanoma	0.000134	0.0117	CcSEcCtD
Icosapent—Vomiting—Dactinomycin—melanoma	0.000133	0.0116	CcSEcCtD
Icosapent—Rash—Dactinomycin—melanoma	0.000132	0.0115	CcSEcCtD
Icosapent—Arthralgia—Docetaxel—melanoma	0.000132	0.0115	CcSEcCtD
Icosapent—Anaphylactic shock—Docetaxel—melanoma	0.000126	0.011	CcSEcCtD
Icosapent—Vomiting—Carmustine—melanoma	0.000125	0.0109	CcSEcCtD
Icosapent—Rash—Carmustine—melanoma	0.000124	0.0108	CcSEcCtD
Icosapent—Dermatitis—Carmustine—melanoma	0.000124	0.0108	CcSEcCtD
Icosapent—Vomiting—Temozolomide—melanoma	0.000121	0.0105	CcSEcCtD
Icosapent—Rash—Temozolomide—melanoma	0.00012	0.0104	CcSEcCtD
Icosapent—Dermatitis—Temozolomide—melanoma	0.000119	0.0104	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Docetaxel—melanoma	0.000115	0.01	CcSEcCtD
Icosapent—Dyspepsia—Docetaxel—melanoma	0.000111	0.00969	CcSEcCtD
Icosapent—Gastrointestinal disorder—Docetaxel—melanoma	0.000109	0.0095	CcSEcCtD
Icosapent—Constipation—Docetaxel—melanoma	0.000108	0.00941	CcSEcCtD
Icosapent—Dihomo-gamma-linolenic acid—PTGS2—melanoma	0.000104	1	CrCbGaD
Icosapent—Pruritus—Docetaxel—melanoma	8.92e-05	0.00779	CcSEcCtD
Icosapent—Vomiting—Docetaxel—melanoma	8.02e-05	0.007	CcSEcCtD
Icosapent—Rash—Docetaxel—melanoma	7.95e-05	0.00694	CcSEcCtD
Icosapent—Dermatitis—Docetaxel—melanoma	7.95e-05	0.00693	CcSEcCtD
Icosapent—PPARG—Developmental Biology—MMP2—melanoma	2.36e-05	0.000105	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MAP2K1—melanoma	2.35e-05	0.000105	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIP4K2A—melanoma	2.34e-05	0.000104	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC6A11—melanoma	2.34e-05	0.000104	CbGpPWpGaD
Icosapent—PTGS2—Disease—CUBN—melanoma	2.33e-05	0.000104	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GPAM—melanoma	2.3e-05	0.000102	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PTEN—melanoma	2.28e-05	0.000101	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PTEN—melanoma	2.28e-05	0.000101	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—PIK3CA—melanoma	2.28e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTAP—melanoma	2.28e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.27e-05	0.000101	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MDM2—melanoma	2.27e-05	0.000101	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—IL6—melanoma	2.26e-05	0.0001	CbGpPWpGaD
Icosapent—PTGS2—Disease—CSPG4—melanoma	2.25e-05	0.0001	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—FGF2—melanoma	2.24e-05	9.95e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ERBB2—melanoma	2.24e-05	9.95e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.23e-05	9.91e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.22e-05	9.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPS3—melanoma	2.21e-05	9.85e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PIK3CB—melanoma	2.21e-05	9.82e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SKI—melanoma	2.18e-05	9.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.17e-05	9.65e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.15e-05	9.55e-05	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PIK3CA—melanoma	2.12e-05	9.44e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCL8—melanoma	2.12e-05	9.43e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP17A1—melanoma	2.12e-05	9.41e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HRAS—melanoma	2.11e-05	9.37e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TP53—melanoma	2.1e-05	9.34e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.1e-05	9.33e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.09e-05	9.31e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.09e-05	9.28e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.08e-05	9.27e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CDKN1B—melanoma	2.07e-05	9.21e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—ERBB2—melanoma	2.06e-05	9.18e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—ALB—melanoma	2.06e-05	9.16e-05	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—AKT1—melanoma	2.05e-05	9.11e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.03e-05	9.03e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CASP3—melanoma	2.03e-05	9.03e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—LUM—melanoma	2.03e-05	9.02e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PHGDH—melanoma	2.03e-05	9.02e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL2—melanoma	2.03e-05	9.02e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL6—melanoma	2.02e-05	8.97e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GNA11—melanoma	2e-05	8.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HPSE—melanoma	1.99e-05	8.85e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCND1—melanoma	1.98e-05	8.79e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CTNNB1—melanoma	1.96e-05	8.7e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PLA2G6—melanoma	1.96e-05	8.7e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—FASN—melanoma	1.96e-05	8.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CUBN—melanoma	1.95e-05	8.68e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CG—melanoma	1.94e-05	8.61e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—CDKN2B—melanoma	1.93e-05	8.59e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—SLC5A5—melanoma	1.92e-05	8.56e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL6—melanoma	1.92e-05	8.55e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MMP9—melanoma	1.92e-05	8.53e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CDKN1A—melanoma	1.91e-05	8.5e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PTEN—melanoma	1.91e-05	8.48e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NFKB1—melanoma	1.9e-05	8.44e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.89e-05	8.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CSPG4—melanoma	1.89e-05	8.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SDHD—melanoma	1.89e-05	8.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—BSG—melanoma	1.89e-05	8.39e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—VDR—melanoma	1.88e-05	8.37e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PPARG—melanoma	1.87e-05	8.31e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—AKT1—melanoma	1.86e-05	8.28e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GNAQ—melanoma	1.86e-05	8.26e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CD44—melanoma	1.86e-05	8.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GPAM—melanoma	1.83e-05	8.12e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.82e-05	8.09e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CTNNB1—melanoma	1.81e-05	8.03e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.8e-05	8.02e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HDAC6—melanoma	1.8e-05	8.01e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.79e-05	7.96e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP1B1—melanoma	1.78e-05	7.92e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PIK3CA—melanoma	1.78e-05	7.91e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP9—melanoma	1.77e-05	7.87e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—VCAN—melanoma	1.76e-05	7.81e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NFKB1—melanoma	1.75e-05	7.79e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.74e-05	7.74e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—PRKCA—melanoma	1.74e-05	7.72e-05	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—AKT1—melanoma	1.73e-05	7.72e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VEGFA—melanoma	1.72e-05	7.66e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ERCC2—melanoma	1.72e-05	7.66e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NPPA—melanoma	1.71e-05	7.59e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—STAT3—melanoma	1.71e-05	7.59e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CD—melanoma	1.7e-05	7.57e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.7e-05	7.57e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NRAS—melanoma	1.7e-05	7.57e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.7e-05	7.57e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ALB—melanoma	1.68e-05	7.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—VCAN—melanoma	1.67e-05	7.41e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.66e-05	7.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—WNT5A—melanoma	1.65e-05	7.35e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MAPK3—melanoma	1.63e-05	7.25e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.62e-05	7.21e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PIK3CA—melanoma	1.61e-05	7.16e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PIK3CA—melanoma	1.61e-05	7.16e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.61e-05	7.15e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.61e-05	7.14e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—VEGFA—melanoma	1.59e-05	7.07e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MYC—melanoma	1.59e-05	7.05e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—STAT3—melanoma	1.57e-05	7e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.57e-05	6.99e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NRAS—melanoma	1.57e-05	6.98e-05	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—MYC—melanoma	1.55e-05	6.91e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PLA2G6—melanoma	1.55e-05	6.91e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MAPK1—melanoma	1.55e-05	6.9e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EGFR—melanoma	1.55e-05	6.9e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MAPK3—melanoma	1.5e-05	6.69e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CB—melanoma	1.48e-05	6.6e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP17A1—melanoma	1.48e-05	6.59e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.48e-05	6.57e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTGS2—melanoma	1.47e-05	6.54e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ABCB1—melanoma	1.47e-05	6.52e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KRAS—melanoma	1.46e-05	6.51e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.46e-05	6.5e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—AKT1—melanoma	1.45e-05	6.47e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	1.44e-05	6.42e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MAPK1—melanoma	1.43e-05	6.36e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EGFR—melanoma	1.43e-05	6.36e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.43e-05	6.35e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MAPK3—melanoma	1.41e-05	6.27e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GNA11—melanoma	1.4e-05	6.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—VCAN—melanoma	1.39e-05	6.2e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—NOTCH1—melanoma	1.39e-05	6.18e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MYC—melanoma	1.37e-05	6.09e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—FASN—melanoma	1.37e-05	6.09e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—melanoma	1.36e-05	6.06e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KRAS—melanoma	1.35e-05	6.01e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PRKCA—melanoma	1.35e-05	6e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SLC5A5—melanoma	1.35e-05	5.99e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PIK3CA—melanoma	1.35e-05	5.99e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ERCC2—melanoma	1.34e-05	5.95e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—GAB2—melanoma	1.33e-05	5.9e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.32e-05	5.87e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—AKT1—melanoma	1.31e-05	5.85e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—AKT1—melanoma	1.31e-05	5.85e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—melanoma	1.3e-05	5.79e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CD44—melanoma	1.3e-05	5.79e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GNAQ—melanoma	1.3e-05	5.79e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FASN—melanoma	1.3e-05	5.78e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTEN—melanoma	1.28e-05	5.7e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.27e-05	5.67e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.27e-05	5.67e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.26e-05	5.62e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP1B1—melanoma	1.25e-05	5.55e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FOXO4—melanoma	1.25e-05	5.55e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HDAC2—melanoma	1.25e-05	5.55e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CXCR4—melanoma	1.25e-05	5.55e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—melanoma	1.24e-05	5.54e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD44—melanoma	1.23e-05	5.49e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.21e-05	5.37e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6—melanoma	1.19e-05	5.3e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP17A1—melanoma	1.18e-05	5.23e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.16e-05	5.16e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HRAS—melanoma	1.15e-05	5.11e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.15e-05	5.1e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT3—melanoma	1.14e-05	5.06e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GNA11—melanoma	1.11e-05	4.94e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.11e-05	4.93e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.1e-05	4.9e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6—melanoma	1.1e-05	4.89e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AKT1—melanoma	1.1e-05	4.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—FASN—melanoma	1.09e-05	4.84e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SLC5A5—melanoma	1.07e-05	4.76e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CG—melanoma	1.06e-05	4.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GNAQ—melanoma	1.03e-05	4.6e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CD44—melanoma	1.03e-05	4.6e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ABCB1—melanoma	1.03e-05	4.57e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—AKT1—melanoma	1.01e-05	4.51e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.01e-05	4.5e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB4—melanoma	1.01e-05	4.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN2B—melanoma	9.97e-06	4.43e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP1B1—melanoma	9.9e-06	4.41e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD86—melanoma	9.64e-06	4.29e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—AKT1—melanoma	9.5e-06	4.23e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PRKCA—melanoma	9.46e-06	4.21e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ERCC2—melanoma	9.38e-06	4.17e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGF1—melanoma	9.35e-06	4.16e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CD—melanoma	9.29e-06	4.13e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ALB—melanoma	9.18e-06	4.08e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PDGFRA—melanoma	9.05e-06	4.03e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CA—melanoma	9.04e-06	4.02e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PRKCA—melanoma	8.96e-06	3.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERCC2—melanoma	8.89e-06	3.95e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAP2K2—melanoma	8.76e-06	3.9e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.74e-06	3.89e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—TERT—melanoma	8.33e-06	3.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HLA-A—melanoma	8.33e-06	3.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RAC1—melanoma	8.31e-06	3.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ABCB1—melanoma	8.16e-06	3.63e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CB—melanoma	8.1e-06	3.6e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTGS2—melanoma	8.03e-06	3.57e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HIF1A—melanoma	7.97e-06	3.54e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.77e-06	3.46e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MAPK3—melanoma	7.69e-06	3.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PRKCA—melanoma	7.51e-06	3.34e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MYC—melanoma	7.48e-06	3.33e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ERCC2—melanoma	7.44e-06	3.31e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CG—melanoma	7.41e-06	3.29e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKT1—melanoma	7.39e-06	3.29e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS2—melanoma	7.25e-06	3.22e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOTCH1—melanoma	7.18e-06	3.19e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPARG—melanoma	7.15e-06	3.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD80—melanoma	7.03e-06	3.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—KIT—melanoma	7.02e-06	3.12e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APC—melanoma	7.02e-06	3.12e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTEN—melanoma	7e-06	3.11e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGF—melanoma	6.94e-06	3.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—BRAF—melanoma	6.6e-06	2.94e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CD—melanoma	6.51e-06	2.9e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALB—melanoma	6.43e-06	2.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAP2K1—melanoma	6.21e-06	2.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CD—melanoma	6.17e-06	2.75e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.17e-06	2.74e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGF2—melanoma	5.91e-06	2.63e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CG—melanoma	5.88e-06	2.62e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CB—melanoma	5.67e-06	2.52e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPARG—melanoma	5.67e-06	2.52e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTGS2—melanoma	5.62e-06	2.5e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MDM2—melanoma	5.53e-06	2.46e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB2—melanoma	5.45e-06	2.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CB—melanoma	5.38e-06	2.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD4—melanoma	5.37e-06	2.39e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—AKT1—melanoma	5.19e-06	2.31e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CD—melanoma	5.17e-06	2.3e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALB—melanoma	5.1e-06	2.27e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1B—melanoma	5.05e-06	2.25e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CA—melanoma	4.94e-06	2.2e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTEN—melanoma	4.9e-06	2.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CTNNB1—melanoma	4.77e-06	2.12e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1A—melanoma	4.66e-06	2.07e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PTEN—melanoma	4.65e-06	2.07e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CB—melanoma	4.51e-06	2e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—STAT3—melanoma	4.16e-06	1.85e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NRAS—melanoma	4.15e-06	1.84e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKT1—melanoma	4.03e-06	1.79e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAPK3—melanoma	3.97e-06	1.77e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PTEN—melanoma	3.89e-06	1.73e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MYC—melanoma	3.86e-06	1.72e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAPK1—melanoma	3.78e-06	1.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGFR—melanoma	3.78e-06	1.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—KRAS—melanoma	3.57e-06	1.59e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CA—melanoma	3.46e-06	1.54e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CA—melanoma	3.28e-06	1.46e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—melanoma	3.03e-06	1.35e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6—melanoma	2.9e-06	1.29e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKT1—melanoma	2.83e-06	1.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CA—melanoma	2.75e-06	1.22e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT1—melanoma	2.68e-06	1.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKT1—melanoma	2.24e-06	9.98e-06	CbGpPWpGaD
